Impact BioMedical Inc.

US$4.10As of Sun 8 Nov 2026, 12:00 UTC
AMEX:IBOHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (57.82%)
Div yield —
ROE 23.46%
Biotechnology
Beta (5Y) 2.89
PE TTM 61.89
TSR TTM (39.29%)
Mkt cap US$35.03M
ROIC (21.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.93
(4.13%)
(39.66%)
Hold 9|6|4|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.07
0.08
24.08%
17.63%
12.97%
7.65%
Revenue$M
3.654
3.646
3.691
3.846
10.20%
6.86%
2.18%
5.28%
Peers (US$35.03M)
Cap (US$)
PE
34.75M
—
Capital
TTM
5Y
10Y
Leveragex
1.240
0.020
0.017
EBIT/Intx
0.764
0.051
0.050
Own earn%
18.44
46.75
40.79
Sh yield%
9.59
39.15
40.08
Owners
Insiders/Inst%
8.25
81.42
Short interest%
4.58
SBC / revenue%
1.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
18–26
$1 testx
0.0
Incr. ROIC%
24